Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma

BACKGROUND: Ovarian carcinoma is highly dependent on the ubiquitin proteasome system (UPS), but its clinical response to treatment with the proteasome inhibitor bortezomib has been disappointing. This has driven exploration of alternate approaches to target the UPS in ovarian cancer. Recently, prote...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Ovarian Res
Autori principali: Jiang, Rosie T., Yemelyanova, Anna, Xing, Deyin, Anchoori, Ravi K., Hamazaki, Jun, Murata, Shigeo, Seidman, Jeffrey D., Wang, Tian-Li, Roden, Richard B. S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2017
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5547474/
https://ncbi.nlm.nih.gov/pubmed/28784174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-017-0347-y
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi